Search research articles
Contact Us
Filters
Showing results (161-170 of 435) with videos related to
Page
of 44
Sort By:
The Journal of Rheumatology
|
November 16, 2020
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
Tanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, et al.
Arthritis and Rheumatism
|
October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis
Arthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
The Lancet. Rheumatology
|
June 22, 2025
Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial
Vibeke Strand, Jerome Msihid, Jennifer Sloane, et al.
Advances in Therapy
|
December 8, 2021
Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
Juliana Setyawan, Fan Mu, Miriam L Zichlin, et al.
RMD Open
|
November 10, 2017
Discordant patient-physician assessments of disease activity and its persistence adversely impact quality of life and work productivity in US Hispanics with rheumatoid arthritis
George A Karpouzas, Sera N Ramadan, Chelsie E Cost, et al.
The Journal of Rheumatology
|
May 26, 2006
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group
Leslie J Crofford, Matthew D Breyer, C Vibeke Strand, et al.
The Journal of Rheumatology
|
August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting
Sarah Romanelli, Beth Childs, Vibeke Strand, et al.
Journal of Medical Economics
|
March 16, 2017
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
Jeroen P Jansen, Devin Incerti, Alex Mutebi, et al.
Lupus
|
March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group
Wils Nielsen, Vibeke Strand, Lee S Simon, et al.
Lupus Science & Medicine
|
June 1, 2025
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial
Marta Mosca, Laurent Arnaud, Anca Askanase, et al.
Page
of 44
Search research articles
Search
Showing results (161-170 of 435) with videos related to
Sort By:
Page
of 44
The Journal of Rheumatology
|
November 16, 2020
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
Tanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, et al.
Arthritis and Rheumatism
|
October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis
Arthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
The Lancet. Rheumatology
|
June 22, 2025
Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial
Vibeke Strand, Jerome Msihid, Jennifer Sloane, et al.
Advances in Therapy
|
December 8, 2021
Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
Juliana Setyawan, Fan Mu, Miriam L Zichlin, et al.
RMD Open
|
November 10, 2017
Discordant patient-physician assessments of disease activity and its persistence adversely impact quality of life and work productivity in US Hispanics with rheumatoid arthritis
George A Karpouzas, Sera N Ramadan, Chelsie E Cost, et al.
The Journal of Rheumatology
|
May 26, 2006
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group
Leslie J Crofford, Matthew D Breyer, C Vibeke Strand, et al.
The Journal of Rheumatology
|
August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting
Sarah Romanelli, Beth Childs, Vibeke Strand, et al.
Journal of Medical Economics
|
March 16, 2017
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
Jeroen P Jansen, Devin Incerti, Alex Mutebi, et al.
Lupus
|
March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group
Wils Nielsen, Vibeke Strand, Lee S Simon, et al.
Lupus Science & Medicine
|
June 1, 2025
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial
Marta Mosca, Laurent Arnaud, Anca Askanase, et al.
Page
of 44